The trypanosomiases

被引:605
作者
Barrett, MP
Burchmore, RJS
Stich, A
Lazzari, JO
Frasch, AC
Cazzulo, JJ
Krishna, S
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
[2] Med Mission Inst, Dept Trop Med & Epidem Control, Wurzburg, Germany
[3] Hosp Pirovano, Div Cardiol, Buenos Aires, DF, Argentina
[4] Univ Nacl Gen San Martin, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina
[5] Univ London St Georges Hosp, Sch Med, Dept Infect Dis, London SW17 0RE, England
关键词
D O I
10.1016/S0140-6736(03)14694-6
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The trypanosomiases consist of a group of important animal and human diseases caused by parasitic protozoa of the genus Trypanosoma. In sub-Saharan Africa, the final decade of the 20th century witnessed an alarming resurgence in sleeping sickness (human African trypanosomiasis). In South and Central America, Chagas' disease (American trypanosomiasis) remains one of the most prevalent infectious diseases. Arthropod vectors transmit African and American trypanosomiases, and disease containment through insect control programmes is an achievable goal. Chemotherapy is available for both diseases, but existing drugs are far from ideal. The trypanosomes are some of the earliest diverging members of the Eukaryotae and share several biochemical peculiarities that have stimulated research into new drug targets. However, differences in the ways in which trypanosome species interact with their hosts have frustrated efforts to design drugs effective against both species. Growth in recognition of these neglected diseases might result in progress towards control through increased funding for drug development and vector elimination.
引用
收藏
页码:1469 / 1480
页数:12
相关论文
共 125 条
[1]
The mucin-like glycoprotein super-family of Trypanosoma cruzi:: structure and biological roles [J].
Acosta-Serrano, A ;
Almeida, IC ;
Freitas, LH ;
Yoshida, N ;
Schenkman, S .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 114 (02) :143-150
[2]
The farnesyltransferase inhibitor manumycin A is a novel trypanocide with a complex mode of action including major effects on mitochondria [J].
Ali, BRS ;
Pal, A ;
Croft, SL ;
Taylor, RJK ;
Field, MC .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1999, 104 (01) :67-80
[3]
Options for vector control against trypanosomiasis in Africa [J].
Allsopp, R .
TRENDS IN PARASITOLOGY, 2001, 17 (01) :15-19
[4]
Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents [J].
Almeida, IC ;
Camargo, MM ;
Procópio, DO ;
Silva, LS ;
Mehlert, A ;
Travassos, LR ;
Gazzinelli, RT ;
Ferguson, MAJ .
EMBO JOURNAL, 2000, 19 (07) :1476-1485
[5]
[Anonymous], 1998, WHO TECHN REP SER, V881
[6]
[Anonymous], MANSONS TROPICAL DIS
[7]
[Anonymous], 2002, World Health Report, 2002: Reducing risks, promoting healthy life
[8]
Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase [J].
Aronov, AM ;
Suresh, S ;
Buckner, FS ;
Van Voorhis, WC ;
Verlinde, CLMJ ;
Opperdoes, FR ;
Hol, WGJ ;
Gelb, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4273-4278
[9]
POLYAMINE METABOLISM - A POTENTIAL THERAPEUTIC TARGET IN TRYPANOSOMES [J].
BACCHI, CJ ;
NATHAN, HC ;
HUTNER, SH .
SCIENCE, 1980, 210 (4467) :332-334
[10]
Barrett Michael P., 2002, Current Topics in Medicinal Chemistry, V2, P471, DOI 10.2174/1568026024607427